摘要1985年，基因重组人生长激素（recombinant human growth hormone，rhGH）问世，为广大矮身材患儿的治疗带来希望。随后，rhGH在临床得到迅速应用，其治疗的有效性得到广泛验证，关于rhGH的治疗范围、治疗方案、疗效以及安全性的研究日益深入。为规范rhGH的应用及矮身材儿童的诊治，
4Ranke MB. Diagnostics of Endocrine function in children and adolescents. Basel :Karger , 2003.
5Ranke MB, Feldt-Rasmussen U, Bang P, et al. How should insulinlike growth factor I be measured? a consensus statement. Horm Res.2001,55 Suppl 2:106-109.
6Chemaitilly W, Trivin C, Souberbielle JC, et al. Assessing shortstatured children for growth hormone deficiency. Horm Res, 2003,60:34-42.
8Tassoni P, Cacciari E, Cau M, et al. variability of growth hormone response to pharamacological and sleep tests performed twice in short children. J Clin Endocrinol metab, 1990,71 : 230-234.
9Cacciari E, Tasseni P, Cieognai A, et al. Value and limits of pharmacological and physiological tests to diagnose growth hormone(GH) deficiency and predict therapy response: Brst and second retesting during replacement therapy of patients defined as GH deficient J Clin Endacrinal Metab 1994,79:1663-1669.
10Goodman HG, Grumbach MM, Kaplan SL Growth and growth-hormone Ⅱ:a comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitarv dwarfism. N Engl J Med. 1968.278:57-68.
